Trial Profile
A Randomized Phase II Trial of Two Different Schedules of Abraxane in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2017
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 09 Oct 2015 Status changed from active, no longer recruiting to discontinued as per ClinicalTrials.gov record.
- 09 Oct 2015 Status changed from active, no longer recruiting to discontinued as per ClinicalTrials.gov record.
- 01 Feb 2013 Planned End Date 1 Jun 2013 added as reported by ClinicalTrials.gov.